Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,611 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04830826 | A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China(ADDRESS) | completed | — | 1,490 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT05292859 | Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs | completed | — | 7 | Alaunos TherapeuticsINDUSTRY |
| 1 |
| Jul 30, 2025 |
| clinicaltrials |
| NCT05303493 | Camu-Camu Prebiotic and Immune Checkpoint Inhibition in Patients With Non-small Cell Lung Cancer and Melanoma | completed | Phase 1 | 45 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT02769832 | Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer | completed | Phase 2 | 32 | Muhammad FurqanOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT02392455 | VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC) | completed | — | 817 | Boehringer IngelheimINDUSTRY | 1 | Jul 28, 2025 | clinicaltrials |
| NCT04051827 | Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 26 | Millennium Pharmaceuticals, Inc.INDUSTRY | 3 | Jul 28, 2025 | clinicaltrials |
| NCT00284778 | Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer | completed | Phase 3 | 150 | University Hospital, LimogesOTHER | 1 | Jul 24, 2025 | clinicaltrials |
| NCT04026412 | A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery(CheckMate73L) | completed | Phase 3 | 925 | Bristol-Myers SquibbINDUSTRY | 27 | Jul 24, 2025 | clinicaltrials |
| NCT06602674 | PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary Lesions | completed | — | 647 | Ruijin HospitalOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT05546905 | A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS) | completed | — | 206 | Pierre Fabre MedicamentINDUSTRY | 5 | Jul 22, 2025 | clinicaltrials |
| NCT03199586 | Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies | completed | Phase 1 | 23 | Novita Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT00199758 | Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 227 | University Hospital, LimogesOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT05651867 | EPIONE Guided Lung Evaluation(EGLE) | completed | N/A | 25 | Quantum SurgicalINDUSTRY | 1 | Jul 15, 2025 | clinicaltrials |
| NCT04242199 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors | completed | Phase 1 | 182 | Incyte CorporationINDUSTRY | 5 | Jul 14, 2025 | clinicaltrials |
| NCT03131037 | Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung Cancer | completed | Phase 1 | 12 | Candel Therapeutics, Inc.INDUSTRY | 1 | Jul 11, 2025 | clinicaltrials |
| NCT04120454 | Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer | completed | Phase 2 | 6 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT04580485 | INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors | completed | Phase 1 | 54 | Incyte CorporationINDUSTRY | 6 | Jul 11, 2025 | clinicaltrials |
| NCT03537378 | Hybrid APC Therapy in Early Central Lung Neoplasms | completed | N/A | 15 | Jiayuan SunOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT02611024 | Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors | completed | Phase 1 / Phase 2 | 316 | PharmaMarINDUSTRY | 6 | Jul 9, 2025 | clinicaltrials |
| NCT07055997 | Robotic-Assisted Navigation for Lung Nodule Localization: A Non-Inferiority Study | completed | N/A | 100 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07000721 | Research on New Diagnosis and Treatment Technologies for Early Lung Cancer | completed | N/A | 92 | Jisong ZhangOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT07053215 | Efficacy of Argon-Helium Cryoablation Plus PD-1 Inhibitors in NSCLC | completed | N/A | 60 | The First Hospital of Hebei Medical UniversityOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT05884099 | Intercostal Cryoanalgesia for Chronic Pain After VATS Lung Resection(CRYO-VATS-2) | completed | N/A | 80 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT03382561 | Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer | completed | Phase 2 | 160 | National Cancer Institute (NCI)NIH | 1 | Jul 3, 2025 | clinicaltrials |
| NCT07049237 | Evidence-Based Nursing for Fatigue and Quality of Life in Lung Cancer Chemotherapy | completed | N/A | 150 | The First Hospital of Hebei Medical UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT07049250 | Evidence-Based Nursing for Psychological Resilience in Lung Cancer Chemotherapy Patients | completed | N/A | 142 | The First Hospital of Hebei Medical UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT07050979 | Goal-Directed Fluid Therapy for Thoracoscopic Lobectomy | completed | N/A | 80 | Cukurova UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT00540982 | Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction | completed | Phase 1 / Phase 2 | 47 | City of Hope Medical CenterOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT04616768 | PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers(PROStep) | completed | Phase 3 | 108 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT04678440 | [18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients | completed | Early Phase 1 | 5 | University of California, DavisOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT02821793 | Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer(PRIORITY) | completed | — | 346 | Institut BergoniéOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT04400188 | A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 25 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jun 29, 2025 | clinicaltrials |
| NCT02078700 | Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. | completed | Phase 2 | 40 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jun 25, 2025 | clinicaltrials |
| NCT02191891 | Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 32 | Boehringer IngelheimINDUSTRY | 4 | Jun 25, 2025 | clinicaltrials |
| NCT04083859 | Digital Outreach Intervention for Lung Cancer Screening(mPATH-Lung) | completed | N/A | 26,998 | Wake Forest University Health SciencesOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06054152 | CX3CR1+T Cell Predict Immunotherapy Efficacy | completed | — | 150 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT07036016 | Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1 | completed | — | 67,818 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 0 | Jun 25, 2025 | clinicaltrials |
| NCT02299141 | Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 20 | Washington University School of MedicineOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT04283994 | Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)(PICSI-H) | completed | N/A | 756 | University of WashingtonOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT05879354 | Active Cycle of Breathing Techniques on Respiratory Distress Symptom Cluster | completed | N/A | 78 | Maltepe UniversityOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT06826677 | REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER(ARAL) | completed | — | 71 | AstraZenecaINDUSTRY | 1 | Jun 24, 2025 | clinicaltrials |
| NCT03267524 | Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers | completed | N/A | 87 | City of Hope Medical CenterOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT03885765 | Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping(CLIPPCAIR) | completed | — | 160 | University Hospital, MontpellierOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT00981058 | First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin(SQUIRE) | completed | Phase 3 | 1,093 | Eli Lilly and CompanyINDUSTRY | 26 | Jun 18, 2025 | clinicaltrials |
| NCT02705820 | Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy(SWIPE) | completed | Phase 2 | 48 | Bank of Cyprus Oncology CentreOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT04314089 | Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902) | completed | Phase 1 | 31 | Edward PatzOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT05435885 | Postoperative Telerehabilitation in Older Adults | completed | N/A | 64 | Pusan National University HospitalOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT05788484 | A Study of CDX-585 in Patients With Advanced Malignancies | completed | Phase 1 | 20 | Celldex TherapeuticsINDUSTRY | 1 | Jun 15, 2025 | clinicaltrials |
| NCT03867175 | Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer | completed | Phase 3 | 5 | Wake Forest University Health SciencesOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT02262325 | Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery | completed | Phase 2 | 21 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 12, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jul 30, 2025source: clinicaltrials